← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2010First marketed drug
Aug 13, 1947First NDA
Dec 5, 1960Last known activity
Apr 26, 2018
Acquired by Hikma on Jun 26, 2018
Timeline
1940s
- Jun 1, 1946
West-Ward Pharmaceutical— Founded
1960s
- Dec 5, 1960
propiomazine— NDA Organization
1990s
- Feb 3, 1995
daunorubicin— NDA Secondary Org
2010s
- Apr 1, 2011
exemestane— Marketing Organization
- Jun 26, 2018
Hikma— Acquired By
Drugs by trial phase (5 distinct, 4 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Approved for
Studied for
Marketed drugs (239)
Recent trials (4)
- NCT03535870Lead sponsorN/AApr 26, 2018
- NCT03429400Lead sponsorPhase 3Apr 17, 2018
- NCT02323399Lead sponsorPhase 4Feb 1, 2015
- NCT01284556Lead sponsorPhase 3Nov 1, 2010
Details
- Founded
- Eatontown, NJ, US Jun 1, 1946
- First NDA
- Dec 5, 1960
- Last known activity
- Apr 26, 2018